US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Fulcrum Therapeutics Inc (FULC)
Fulcrum Therapeutics Inc (FULC) ニュース

FULC

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FULC

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/06/19	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/06/19	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/06/18	05 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/05/13	20 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/05/13	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/05/10	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/03/09	08 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/03/09	08 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/03/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/28	07 : 18	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/28	07 : 12	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/28	06 : 01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/27	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/01/31	11 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/01/31	11 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/11/07	21 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/11/07	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/10/03	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/22	20 : 48	Dow Jones News	Fulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study Hold	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/22	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/12	05 : 53	GlobeNewswire Inc.	Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/03	20 : 11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/03	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/07/11	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/07/08	06 : 30	GlobeNewswire Inc.	Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/07/04	05 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/06/30	05 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/06/30	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/06/30	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FULC	Fulcrum Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:FULC

1 2 3 4 5 6 7 8 9 10 次へ >>

Datable Technology

Hamilton US Bond YIELD M...

DGB Asia Berhad (GM)

Fidelity Advisor Sustain...

Jubilee Gold Exploration

Alerion Cleanpower

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約